If you do not notice any appetite change after 10 days, contact your PlexusDx provider to discuss whether your dose needs adjustment
Pancreatitis Pancreatitis (inflammation of the pancreas) is a rare but serious side effect reported with Ozempic and other GLP-1 medicines
The proportion of participants in the semaglutide group who achieved substantial weight loss also exceeded the proportion of those who did so in the placebo group, with 76% (99 out of 131) participants on semaglutide exhibiting a body weight reduction of at least 5%, compared with 18% (11 out of 62) on placebo (estimated OR: 14.0
Its triple-agonist mechanism targeting GLP-1, GIP, and glucagon simultaneously is genuinely novel, and the liver fat reduction data (82% at 24 weeks, per Sanyal et al., Nature Medicine 2024) is in a class of its own
Citation: ClinicalTrials.gov
If the powder appears clumped, discolored, or wet, do not use it